172 related articles for article (PubMed ID: 11121368)
1. Evidence for neuronal dysfunction in migraine: concurrence between specific qEEG findings and clinical drug response--a retrospective analysis-.
Vonderheid-Guth B; Todorova A; Wedekind W; Dimpfel W
Eur J Med Res; 2000 Nov; 5(11):473-83. PubMed ID: 11121368
[TBL] [Abstract][Full Text] [Related]
2. Functional imaging of headache - first steps in an objective quantitative classification of migraine.
Sauer S; Schellenberg R; Hofmann HC; Dimpfel W
Eur J Med Res; 1997 Sep; 2(9):367-76. PubMed ID: 9300933
[TBL] [Abstract][Full Text] [Related]
3. Quantitative electroencephalography power analysis in subjective idiopathic tinnitus patients: a clinical paradigm shift in the understanding of tinnitus, an electrophysiological correlate.
Shulman A; Avitable MJ; Goldstein B
Int Tinnitus J; 2006; 12(2):121-31. PubMed ID: 17260877
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional localization of abnormal EEG activity in migraine: a low resolution electromagnetic tomography (LORETA) study of migraine patients in the pain-free interval.
Clemens B; Bánk J; Piros P; Bessenyei M; Veto S; Tóth M; Kondákor I
Brain Topogr; 2008 Sep; 21(1):36-42. PubMed ID: 18679787
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and central mechanisms of cyclandelate in migraine: a double-blind placebo-controlled study.
Siniatchkin M; Gerber WD; Vein A
Funct Neurol; 1998; 13(1):47-56. PubMed ID: 9584874
[TBL] [Abstract][Full Text] [Related]
6. The occipital alpha rhythm related to the "migraine cycle" and headache burden: a blinded, controlled longitudinal study.
Bjørk MH; Stovner LJ; Nilsen BM; Stjern M; Hagen K; Sand T
Clin Neurophysiol; 2009 Mar; 120(3):464-71. PubMed ID: 19157973
[TBL] [Abstract][Full Text] [Related]
7. Quantitative EEG power and asymmetry increase 36 h before a migraine attack.
Bjørk M; Sand T
Cephalalgia; 2008 Sep; 28(9):960-8. PubMed ID: 18624805
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerance of cyclandelate versus pizotifen in the prophylaxis of migraine.
Mastrosimone F; Iaccarino C; de Caterina G
J Med; 1992; 23(1):1-16. PubMed ID: 1573338
[TBL] [Abstract][Full Text] [Related]
9. Migraine changes with age: IMPACT on migraine classification.
Kelman L
Headache; 2006; 46(7):1161-71. PubMed ID: 16866720
[TBL] [Abstract][Full Text] [Related]
10. Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study.
Gerber WD; Schellenberg R; Thom M; Haufe C; Bölsche F; Wedekind W; Niederberger U; Soyka D
Funct Neurol; 1995; 10(1):27-35. PubMed ID: 7649498
[TBL] [Abstract][Full Text] [Related]
11. Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects.
Young W; Shaw J; Bloom M; Gebeline-Myers C
Headache; 2008; 48(10):1490-8. PubMed ID: 19076647
[TBL] [Abstract][Full Text] [Related]
12. Quantitative EEG asymmetry correlates with clinical severity in unilateral Sturge-Weber syndrome.
Hatfield LA; Crone NE; Kossoff EH; Ewen JB; Pyzik PL; Lin DD; Kelley TM; Comi AM
Epilepsia; 2007 Jan; 48(1):191-5. PubMed ID: 17241228
[TBL] [Abstract][Full Text] [Related]
13. Cyclandelate in the prophylaxis of migraine: a placebo-controlled study.
Diener HC; Krupp P; Schmitt T; Steitz G; Milde K; Freytag S
Cephalalgia; 2001 Feb; 21(1):66-70. PubMed ID: 11298666
[TBL] [Abstract][Full Text] [Related]
14. How the brain anticipates an attack: a study of neurophysiological periodicity in migraine.
Siniatchkin M; Gerber WD; Kropp P; Vein A
Funct Neurol; 1999; 14(2):69-77. PubMed ID: 10399619
[TBL] [Abstract][Full Text] [Related]
15. Visually evoked phase synchronization changes of alpha rhythm in migraine: correlations with clinical features.
de Tommaso M; Marinazzo D; Guido M; Libro G; Stramaglia S; Nitti L; Lattanzi G; Angelini L; Pellicoro M
Int J Psychophysiol; 2005 Sep; 57(3):203-10. PubMed ID: 16109290
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
17. Flunarizine for prophylactic treatment of childhood migraine.
Visudtibhan A; Lusawat A; Chiemchanya S; Visudhiphan P
J Med Assoc Thai; 2004 Dec; 87(12):1466-70. PubMed ID: 15822542
[TBL] [Abstract][Full Text] [Related]
18. Clinical correlates of quantitative EEG alterations in alcoholic patients.
Coutin-Churchman P; Moreno R; Añez Y; Vergara F
Clin Neurophysiol; 2006 Apr; 117(4):740-51. PubMed ID: 16495144
[TBL] [Abstract][Full Text] [Related]
19. Reduction in the therapeutic intensity of abortive migraine drug use during ACE inhibition therapy--a pilot study.
Rahimtoola H; Buurma H; Tijssen CC; Leufkens HG; Egberts AC
Pharmacoepidemiol Drug Saf; 2004 Jan; 13(1):41-7. PubMed ID: 14971122
[TBL] [Abstract][Full Text] [Related]
20. Clozapine-induced QEEG changes correlate with clinical response in schizophrenic patients: a prospective, longitudinal study.
Gross A; Joutsiniemi SL; Rimon R; Appelberg B
Pharmacopsychiatry; 2004 May; 37(3):119-22. PubMed ID: 15138895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
